Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Angion Biomedica Corp. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Angion Biomedica Corp. for $942,288.0 USD from the U.S. Department of Health & Human Services.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 May, 2021
"SBA agency remap"
Golden AI profile picture
Golden AI
edited on 8 May, 2021
Edits made to:
Infobox (+1/-1 properties)
Infobox
Agency
United States Department of Health and Human Services
United States Department of Health and Human Services
Agency
Edits on 13 Mar, 2021
"Created via: SBIR import"
Golden AI profile picture
Golden AI
created this topic on 13 Mar, 2021
Edits made to:
Infobox (+8 properties)
‌

 Angion Biomedica Corp. SBIR Phase II Award,

Infobox
Is a
SBIR/STTR Awards
SBIR/STTR Awards
Recipient
Angion Biomedica Corp.
Angion Biomedica Corp.
Agency
United States Department of Health and Human Services
United States Department of Health and Human Services
Award Type
SBIR
Award Identifier
2R44NS053152-02
Phase
Phase II
Amount (USD)
942,288
Website
https://www.sbir.gov/content/novel-small-molecule-therapeutic-spinal-cord-injury-2

Find more entities like Angion Biomedica Corp. SBIR Phase II Award,

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.